SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
Jun 21, 2018	424B7	424B7	0001144204-18-035109.pdf 0001144204-18-035109.rtf 0001144204-18-035109.xls View HTML
Jan 29, 2019	424B7	424B7	0001144204-19-003213.pdf 0001144204-19-003213.rtf 0001144204-19-003213.xls View HTML
May 8, 2001	DEFS14A	A definitive proxy statement giving notice regarding a special meeting	0001050502-01-500046.pdf 0001050502-01-500046.rtf View HTML
May 31, 2002	PRE 14C	A preliminary proxy statement containing all other information	0001000096-02-000342.pdf 0001000096-02-000342.rtf View HTML
Jan 17, 2014	PRE 14C	A preliminary proxy statement containing all other information	0001424884-14-000011.pdf 0001424884-14-000011.rtf 0001424884-14-000011.xls View HTML
Jan 6, 2010	PRE 14C	A preliminary proxy statement containing all other information	0001424884-10-000002.pdf 0001424884-10-000002.rtf 0001424884-10-000002.xls View HTML
Apr 27, 2001	PRES14A	A preliminary proxy statement giving notice regarding a special meeting	0001000096-01-500049.pdf 0001000096-01-500049.rtf View HTML
Mar 5, 2004	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001092306-04-000143.pdf 0001092306-04-000143.rtf View HTML
Feb 16, 2007	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001183740-07-000082.pdf 0001183740-07-000082.rtf 0001183740-07-000082.xls View HTML
Dec 10, 2008	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	0001183740-08-000648.pdf 0001183740-08-000648.rtf 0001183740-08-000648.xls View HTML

Data provided by Kaleidoscope.